Global Radiopharmaceuticals in Nuclear Medicine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

According to our (Global Info Research) latest study, the global Radiopharmaceuticals in Nuclear Medicine market size was valued at US$ 6301 million in 2023 and is forecast to a readjusted size of USD 10380 million by 2030 with a CAGR of 7.1% during review period.

The radiopharmaceutical market is driven primarily by the growing prevalence of cancer and cardiovascular diseases, which require precise diagnostic tools for early detection and treatment. The increasing adoption of nuclear medicine imaging techniques, such as PET and SPECT scans, has further fueled demand for radiopharmaceuticals. Additionally, technological advancements in radiopharmaceuticals, along with the development of new radioisotopes for more targeted therapies, are expanding the applications of these drugs, making them critical in personalized medicine.

Despite the promising growth, the radiopharmaceutical market faces significant challenges, including the high cost of production and the short half-life of many radioisotopes, which complicates distribution and storage. Regulatory hurdles are another barrier, as radiopharmaceuticals require stringent approval processes due to their radioactive nature. Moreover, limited availability of specialized infrastructure and the shortage of trained professionals in nuclear medicine also hinder widespread adoption, especially in developing regions.

There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions. In developed countries (a quarter of the world population) about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this.

Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs, or to treat disease. In most cases, the information is used by physicians to make a quick diagnosis of the patient's illness. The thyroid, bones, heart, liver, and many other organs can be easily imaged, and disorders in their function revealed. In some cases radiation can be used to treat diseased organs, or tumours.

Over 10,000 hospitals worldwide use radioisotopes in medicine, and about 90% of the procedures are for diagnosis. The most common radioisotope used in diagnosis is technetium-99 (Tc-99m) accounting for about 80% of all nuclear medicine procedures and 85% of diagnostic scans in nuclear medicine worldwide.Over 50 million nuclear medicine procedures are performed each year, and demand for radioisotopes is increasing.

This report is a detailed and comprehensive analysis for global Radiopharmaceuticals in Nuclear Medicine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Radiopharmaceuticals in Nuclear Medicine market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2019-2030
Global Radiopharmaceuticals in Nuclear Medicine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2019-2030
Global Radiopharmaceuticals in Nuclear Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2019-2030
Global Radiopharmaceuticals in Nuclear Medicine market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Radiopharmaceuticals in Nuclear Medicine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Radiopharmaceuticals in Nuclear Medicine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cardinal Health, GE Healthcare, Jubilant Pharma, Novartis, Curium Pharma, SIEMENS, Lantheus, Bracco Imaging, Bayer, Eli Lilly, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Radiopharmaceuticals in Nuclear Medicine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Diagnostic Radiopharmaceuticals
    Therapy Radiopharmaceuticals

Market segment by Application
    Oncology
    Cardiology
    Other

Major players covered
    Cardinal Health
    GE Healthcare
    Jubilant Pharma
    Novartis
    Curium Pharma
    SIEMENS
    Lantheus
    Bracco Imaging
    Bayer
    Eli Lilly
    Aurobindo Pharma
    Mundipharma
    China Isotope & Radiation
    Dongcheng

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Radiopharmaceuticals in Nuclear Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Radiopharmaceuticals in Nuclear Medicine, with price, sales quantity, revenue, and global market share of Radiopharmaceuticals in Nuclear Medicine from 2019 to 2024.
Chapter 3, the Radiopharmaceuticals in Nuclear Medicine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiopharmaceuticals in Nuclear Medicine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Radiopharmaceuticals in Nuclear Medicine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Radiopharmaceuticals in Nuclear Medicine.
Chapter 14 and 15, to describe Radiopharmaceuticals in Nuclear Medicine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Radiopharmaceuticals in Nuclear Medicine Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Diagnostic Radiopharmaceuticals
        1.3.3 Therapy Radiopharmaceuticals
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Radiopharmaceuticals in Nuclear Medicine Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Oncology
        1.4.3 Cardiology
        1.4.4 Other
    1.5 Global Radiopharmaceuticals in Nuclear Medicine Market Size & Forecast
        1.5.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Radiopharmaceuticals in Nuclear Medicine Sales Quantity (2019-2030)
        1.5.3 Global Radiopharmaceuticals in Nuclear Medicine Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Cardinal Health
        2.1.1 Cardinal Health Details
        2.1.2 Cardinal Health Major Business
        2.1.3 Cardinal Health Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.1.4 Cardinal Health Radiopharmaceuticals in Nuclear Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Cardinal Health Recent Developments/Updates
    2.2 GE Healthcare
        2.2.1 GE Healthcare Details
        2.2.2 GE Healthcare Major Business
        2.2.3 GE Healthcare Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.2.4 GE Healthcare Radiopharmaceuticals in Nuclear Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 GE Healthcare Recent Developments/Updates
    2.3 Jubilant Pharma
        2.3.1 Jubilant Pharma Details
        2.3.2 Jubilant Pharma Major Business
        2.3.3 Jubilant Pharma Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.3.4 Jubilant Pharma Radiopharmaceuticals in Nuclear Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Jubilant Pharma Recent Developments/Updates
    2.4 Novartis
        2.4.1 Novartis Details
        2.4.2 Novartis Major Business
        2.4.3 Novartis Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.4.4 Novartis Radiopharmaceuticals in Nuclear Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Novartis Recent Developments/Updates
    2.5 Curium Pharma
        2.5.1 Curium Pharma Details
        2.5.2 Curium Pharma Major Business
        2.5.3 Curium Pharma Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.5.4 Curium Pharma Radiopharmaceuticals in Nuclear Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Curium Pharma Recent Developments/Updates
    2.6 SIEMENS
        2.6.1 SIEMENS Details
        2.6.2 SIEMENS Major Business
        2.6.3 SIEMENS Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.6.4 SIEMENS Radiopharmaceuticals in Nuclear Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 SIEMENS Recent Developments/Updates
    2.7 Lantheus
        2.7.1 Lantheus Details
        2.7.2 Lantheus Major Business
        2.7.3 Lantheus Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.7.4 Lantheus Radiopharmaceuticals in Nuclear Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Lantheus Recent Developments/Updates
    2.8 Bracco Imaging
        2.8.1 Bracco Imaging Details
        2.8.2 Bracco Imaging Major Business
        2.8.3 Bracco Imaging Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.8.4 Bracco Imaging Radiopharmaceuticals in Nuclear Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Bracco Imaging Recent Developments/Updates
    2.9 Bayer
        2.9.1 Bayer Details
        2.9.2 Bayer Major Business
        2.9.3 Bayer Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.9.4 Bayer Radiopharmaceuticals in Nuclear Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Bayer Recent Developments/Updates
    2.10 Eli Lilly
        2.10.1 Eli Lilly Details
        2.10.2 Eli Lilly Major Business
        2.10.3 Eli Lilly Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.10.4 Eli Lilly Radiopharmaceuticals in Nuclear Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Eli Lilly Recent Developments/Updates
    2.11 Aurobindo Pharma
        2.11.1 Aurobindo Pharma Details
        2.11.2 Aurobindo Pharma Major Business
        2.11.3 Aurobindo Pharma Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.11.4 Aurobindo Pharma Radiopharmaceuticals in Nuclear Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Aurobindo Pharma Recent Developments/Updates
    2.12 Mundipharma
        2.12.1 Mundipharma Details
        2.12.2 Mundipharma Major Business
        2.12.3 Mundipharma Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.12.4 Mundipharma Radiopharmaceuticals in Nuclear Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Mundipharma Recent Developments/Updates
    2.13 China Isotope & Radiation
        2.13.1 China Isotope & Radiation Details
        2.13.2 China Isotope & Radiation Major Business
        2.13.3 China Isotope & Radiation Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.13.4 China Isotope & Radiation Radiopharmaceuticals in Nuclear Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 China Isotope & Radiation Recent Developments/Updates
    2.14 Dongcheng
        2.14.1 Dongcheng Details
        2.14.2 Dongcheng Major Business
        2.14.3 Dongcheng Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.14.4 Dongcheng Radiopharmaceuticals in Nuclear Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Dongcheng Recent Developments/Updates

3 Competitive Environment: Radiopharmaceuticals in Nuclear Medicine by Manufacturer
    3.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturer (2019-2024)
    3.3 Global Radiopharmaceuticals in Nuclear Medicine Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Radiopharmaceuticals in Nuclear Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Radiopharmaceuticals in Nuclear Medicine Manufacturer Market Share in 2023
        3.4.3 Top 6 Radiopharmaceuticals in Nuclear Medicine Manufacturer Market Share in 2023
    3.5 Radiopharmaceuticals in Nuclear Medicine Market: Overall Company Footprint Analysis
        3.5.1 Radiopharmaceuticals in Nuclear Medicine Market: Region Footprint
        3.5.2 Radiopharmaceuticals in Nuclear Medicine Market: Company Product Type Footprint
        3.5.3 Radiopharmaceuticals in Nuclear Medicine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Region
        4.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Region (2019-2030)
        4.1.2 Global Radiopharmaceuticals in Nuclear Medicine Consumption Value by Region (2019-2030)
        4.1.3 Global Radiopharmaceuticals in Nuclear Medicine Average Price by Region (2019-2030)
    4.2 North America Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030)
    4.3 Europe Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030)
    4.4 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030)
    4.5 South America Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030)
    4.6 Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Type (2019-2030)
    5.2 Global Radiopharmaceuticals in Nuclear Medicine Consumption Value by Type (2019-2030)
    5.3 Global Radiopharmaceuticals in Nuclear Medicine Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Application (2019-2030)
    6.2 Global Radiopharmaceuticals in Nuclear Medicine Consumption Value by Application (2019-2030)
    6.3 Global Radiopharmaceuticals in Nuclear Medicine Average Price by Application (2019-2030)

7 North America
    7.1 North America Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Type (2019-2030)
    7.2 North America Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Application (2019-2030)
    7.3 North America Radiopharmaceuticals in Nuclear Medicine Market Size by Country
        7.3.1 North America Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Country (2019-2030)
        7.3.2 North America Radiopharmaceuticals in Nuclear Medicine Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Type (2019-2030)
    8.2 Europe Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Application (2019-2030)
    8.3 Europe Radiopharmaceuticals in Nuclear Medicine Market Size by Country
        8.3.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Country (2019-2030)
        8.3.2 Europe Radiopharmaceuticals in Nuclear Medicine Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Size by Region
        9.3.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 South Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Type (2019-2030)
    10.2 South America Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Application (2019-2030)
    10.3 South America Radiopharmaceuticals in Nuclear Medicine Market Size by Country
        10.3.1 South America Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Country (2019-2030)
        10.3.2 South America Radiopharmaceuticals in Nuclear Medicine Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Size by Country
        11.3.1 Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Radiopharmaceuticals in Nuclear Medicine Market Drivers
    12.2 Radiopharmaceuticals in Nuclear Medicine Market Restraints
    12.3 Radiopharmaceuticals in Nuclear Medicine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Radiopharmaceuticals in Nuclear Medicine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Radiopharmaceuticals in Nuclear Medicine
    13.3 Radiopharmaceuticals in Nuclear Medicine Production Process
    13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Radiopharmaceuticals in Nuclear Medicine Typical Distributors
    14.3 Radiopharmaceuticals in Nuclear Medicine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Radiopharmaceuticals in Nuclear Medicine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Radiopharmaceuticals in Nuclear Medicine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. Cardinal Health Basic Information, Manufacturing Base and Competitors
 Table 4. Cardinal Health Major Business
 Table 5. Cardinal Health Radiopharmaceuticals in Nuclear Medicine Product and Services
 Table 6. Cardinal Health Radiopharmaceuticals in Nuclear Medicine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 7. Cardinal Health Recent Developments/Updates
 Table 8. GE Healthcare Basic Information, Manufacturing Base and Competitors
 Table 9. GE Healthcare Major Business
 Table 10. GE Healthcare Radiopharmaceuticals in Nuclear Medicine Product and Services
 Table 11. GE Healthcare Radiopharmaceuticals in Nuclear Medicine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 12. GE Healthcare Recent Developments/Updates
 Table 13. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
 Table 14. Jubilant Pharma Major Business
 Table 15. Jubilant Pharma Radiopharmaceuticals in Nuclear Medicine Product and Services
 Table 16. Jubilant Pharma Radiopharmaceuticals in Nuclear Medicine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 17. Jubilant Pharma Recent Developments/Updates
 Table 18. Novartis Basic Information, Manufacturing Base and Competitors
 Table 19. Novartis Major Business
 Table 20. Novartis Radiopharmaceuticals in Nuclear Medicine Product and Services
 Table 21. Novartis Radiopharmaceuticals in Nuclear Medicine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 22. Novartis Recent Developments/Updates
 Table 23. Curium Pharma Basic Information, Manufacturing Base and Competitors
 Table 24. Curium Pharma Major Business
 Table 25. Curium Pharma Radiopharmaceuticals in Nuclear Medicine Product and Services
 Table 26. Curium Pharma Radiopharmaceuticals in Nuclear Medicine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 27. Curium Pharma Recent Developments/Updates
 Table 28. SIEMENS Basic Information, Manufacturing Base and Competitors
 Table 29. SIEMENS Major Business
 Table 30. SIEMENS Radiopharmaceuticals in Nuclear Medicine Product and Services
 Table 31. SIEMENS Radiopharmaceuticals in Nuclear Medicine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 32. SIEMENS Recent Developments/Updates
 Table 33. Lantheus Basic Information, Manufacturing Base and Competitors
 Table 34. Lantheus Major Business
 Table 35. Lantheus Radiopharmaceuticals in Nuclear Medicine Product and Services
 Table 36. Lantheus Radiopharmaceuticals in Nuclear Medicine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 37. Lantheus Recent Developments/Updates
 Table 38. Bracco Imaging Basic Information, Manufacturing Base and Competitors
 Table 39. Bracco Imaging Major Business
 Table 40. Bracco Imaging Radiopharmaceuticals in Nuclear Medicine Product and Services
 Table 41. Bracco Imaging Radiopharmaceuticals in Nuclear Medicine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 42. Bracco Imaging Recent Developments/Updates
 Table 43. Bayer Basic Information, Manufacturing Base and Competitors
 Table 44. Bayer Major Business
 Table 45. Bayer Radiopharmaceuticals in Nuclear Medicine Product and Services
 Table 46. Bayer Radiopharmaceuticals in Nuclear Medicine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 47. Bayer Recent Developments/Updates
 Table 48. Eli Lilly Basic Information, Manufacturing Base and Competitors
 Table 49. Eli Lilly Major Business
 Table 50. Eli Lilly Radiopharmaceuticals in Nuclear Medicine Product and Services
 Table 51. Eli Lilly Radiopharmaceuticals in Nuclear Medicine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 52. Eli Lilly Recent Developments/Updates
 Table 53. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
 Table 54. Aurobindo Pharma Major Business
 Table 55. Aurobindo Pharma Radiopharmaceuticals in Nuclear Medicine Product and Services
 Table 56. Aurobindo Pharma Radiopharmaceuticals in Nuclear Medicine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 57. Aurobindo Pharma Recent Developments/Updates
 Table 58. Mundipharma Basic Information, Manufacturing Base and Competitors
 Table 59. Mundipharma Major Business
 Table 60. Mundipharma Radiopharmaceuticals in Nuclear Medicine Product and Services
 Table 61. Mundipharma Radiopharmaceuticals in Nuclear Medicine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 62. Mundipharma Recent Developments/Updates
 Table 63. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
 Table 64. China Isotope & Radiation Major Business
 Table 65. China Isotope & Radiation Radiopharmaceuticals in Nuclear Medicine Product and Services
 Table 66. China Isotope & Radiation Radiopharmaceuticals in Nuclear Medicine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 67. China Isotope & Radiation Recent Developments/Updates
 Table 68. Dongcheng Basic Information, Manufacturing Base and Competitors
 Table 69. Dongcheng Major Business
 Table 70. Dongcheng Radiopharmaceuticals in Nuclear Medicine Product and Services
 Table 71. Dongcheng Radiopharmaceuticals in Nuclear Medicine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 72. Dongcheng Recent Developments/Updates
 Table 73. Global Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Manufacturer (2019-2024) & (K Dose)
 Table 74. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturer (2019-2024) & (USD Million)
 Table 75. Global Radiopharmaceuticals in Nuclear Medicine Average Price by Manufacturer (2019-2024) & (US$/Dose)
 Table 76. Market Position of Manufacturers in Radiopharmaceuticals in Nuclear Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 77. Head Office and Radiopharmaceuticals in Nuclear Medicine Production Site of Key Manufacturer
 Table 78. Radiopharmaceuticals in Nuclear Medicine Market: Company Product Type Footprint
 Table 79. Radiopharmaceuticals in Nuclear Medicine Market: Company Product Application Footprint
 Table 80. Radiopharmaceuticals in Nuclear Medicine New Market Entrants and Barriers to Market Entry
 Table 81. Radiopharmaceuticals in Nuclear Medicine Mergers, Acquisition, Agreements, and Collaborations
 Table 82. Global Radiopharmaceuticals in Nuclear Medicine Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
 Table 83. Global Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Region (2019-2024) & (K Dose)
 Table 84. Global Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Region (2025-2030) & (K Dose)
 Table 85. Global Radiopharmaceuticals in Nuclear Medicine Consumption Value by Region (2019-2024) & (USD Million)
 Table 86. Global Radiopharmaceuticals in Nuclear Medicine Consumption Value by Region (2025-2030) & (USD Million)
 Table 87. Global Radiopharmaceuticals in Nuclear Medicine Average Price by Region (2019-2024) & (US$/Dose)
 Table 88. Global Radiopharmaceuticals in Nuclear Medicine Average Price by Region (2025-2030) & (US$/Dose)
 Table 89. Global Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Type (2019-2024) & (K Dose)
 Table 90. Global Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Type (2025-2030) & (K Dose)
 Table 91. Global Radiopharmaceuticals in Nuclear Medicine Consumption Value by Type (2019-2024) & (USD Million)
 Table 92. Global Radiopharmaceuticals in Nuclear Medicine Consumption Value by Type (2025-2030) & (USD Million)
 Table 93. Global Radiopharmaceuticals in Nuclear Medicine Average Price by Type (2019-2024) & (US$/Dose)
 Table 94. Global Radiopharmaceuticals in Nuclear Medicine Average Price by Type (2025-2030) & (US$/Dose)
 Table 95. Global Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Application (2019-2024) & (K Dose)
 Table 96. Global Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Application (2025-2030) & (K Dose)
 Table 97. Global Radiopharmaceuticals in Nuclear Medicine Consumption Value by Application (2019-2024) & (USD Million)
 Table 98. Global Radiopharmaceuticals in Nuclear Medicine Consumption Value by Application (2025-2030) & (USD Million)
 Table 99. Global Radiopharmaceuticals in Nuclear Medicine Average Price by Application (2019-2024) & (US$/Dose)
 Table 100. Global Radiopharmaceuticals in Nuclear Medicine Average Price by Application (2025-2030) & (US$/Dose)
 Table 101. North America Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Type (2019-2024) & (K Dose)
 Table 102. North America Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Type (2025-2030) & (K Dose)
 Table 103. North America Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Application (2019-2024) & (K Dose)
 Table 104. North America Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Application (2025-2030) & (K Dose)
 Table 105. North America Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Country (2019-2024) & (K Dose)
 Table 106. North America Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Country (2025-2030) & (K Dose)
 Table 107. North America Radiopharmaceuticals in Nuclear Medicine Consumption Value by Country (2019-2024) & (USD Million)
 Table 108. North America Radiopharmaceuticals in Nuclear Medicine Consumption Value by Country (2025-2030) & (USD Million)
 Table 109. Europe Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Type (2019-2024) & (K Dose)
 Table 110. Europe Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Type (2025-2030) & (K Dose)
 Table 111. Europe Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Application (2019-2024) & (K Dose)
 Table 112. Europe Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Application (2025-2030) & (K Dose)
 Table 113. Europe Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Country (2019-2024) & (K Dose)
 Table 114. Europe Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Country (2025-2030) & (K Dose)
 Table 115. Europe Radiopharmaceuticals in Nuclear Medicine Consumption Value by Country (2019-2024) & (USD Million)
 Table 116. Europe Radiopharmaceuticals in Nuclear Medicine Consumption Value by Country (2025-2030) & (USD Million)
 Table 117. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Type (2019-2024) & (K Dose)
 Table 118. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Type (2025-2030) & (K Dose)
 Table 119. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Application (2019-2024) & (K Dose)
 Table 120. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Application (2025-2030) & (K Dose)
 Table 121. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Region (2019-2024) & (K Dose)
 Table 122. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Region (2025-2030) & (K Dose)
 Table 123. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Consumption Value by Region (2019-2024) & (USD Million)
 Table 124. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Consumption Value by Region (2025-2030) & (USD Million)
 Table 125. South America Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Type (2019-2024) & (K Dose)
 Table 126. South America Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Type (2025-2030) & (K Dose)
 Table 127. South America Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Application (2019-2024) & (K Dose)
 Table 128. South America Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Application (2025-2030) & (K Dose)
 Table 129. South America Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Country (2019-2024) & (K Dose)
 Table 130. South America Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Country (2025-2030) & (K Dose)
 Table 131. South America Radiopharmaceuticals in Nuclear Medicine Consumption Value by Country (2019-2024) & (USD Million)
 Table 132. South America Radiopharmaceuticals in Nuclear Medicine Consumption Value by Country (2025-2030) & (USD Million)
 Table 133. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Type (2019-2024) & (K Dose)
 Table 134. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Type (2025-2030) & (K Dose)
 Table 135. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Application (2019-2024) & (K Dose)
 Table 136. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Application (2025-2030) & (K Dose)
 Table 137. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Country (2019-2024) & (K Dose)
 Table 138. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales Quantity by Country (2025-2030) & (K Dose)
 Table 139. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Consumption Value by Country (2019-2024) & (USD Million)
 Table 140. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Consumption Value by Country (2025-2030) & (USD Million)
 Table 141. Radiopharmaceuticals in Nuclear Medicine Raw Material
 Table 142. Key Manufacturers of Radiopharmaceuticals in Nuclear Medicine Raw Materials
 Table 143. Radiopharmaceuticals in Nuclear Medicine Typical Distributors
 Table 144. Radiopharmaceuticals in Nuclear Medicine Typical Customers


List of Figures
 Figure 1. Radiopharmaceuticals in Nuclear Medicine Picture
 Figure 2. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type in 2023
 Figure 4. Diagnostic Radiopharmaceuticals Examples
 Figure 5. Therapy Radiopharmaceuticals Examples
 Figure 6. Global Radiopharmaceuticals in Nuclear Medicine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 7. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application in 2023
 Figure 8. Oncology Examples
 Figure 9. Cardiology Examples
 Figure 10. Other Examples
 Figure 11. Global Radiopharmaceuticals in Nuclear Medicine Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 12. Global Radiopharmaceuticals in Nuclear Medicine Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 13. Global Radiopharmaceuticals in Nuclear Medicine Sales Quantity (2019-2030) & (K Dose)
 Figure 14. Global Radiopharmaceuticals in Nuclear Medicine Price (2019-2030) & (US$/Dose)
 Figure 15. Global Radiopharmaceuticals in Nuclear Medicine Sales Quantity Market Share by Manufacturer in 2023
 Figure 16. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Manufacturer in 2023
 Figure 17. Producer Shipments of Radiopharmaceuticals in Nuclear Medicine by Manufacturer Sales ($MM) and Market Share (%): 2023
 Figure 18. Top 3 Radiopharmaceuticals in Nuclear Medicine Manufacturer (Revenue) Market Share in 2023
 Figure 19. Top 6 Radiopharmaceuticals in Nuclear Medicine Manufacturer (Revenue) Market Share in 2023
 Figure 20. Global Radiopharmaceuticals in Nuclear Medicine Sales Quantity Market Share by Region (2019-2030)
 Figure 21. Global Radiopharmaceuticals in Nuclear Medicine Consumption Value Market Share by Region (2019-2030)
 Figure 22. North America Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030) & (USD Million)
 Figure 23. Europe Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030) & (USD Million)
 Figure 24. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030) & (USD Million)
 Figure 25. South America Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030) & (USD Million)
 Figure 26. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030) & (USD Million)
 Figure 27. Global Radiopharmaceuticals in Nuclear Medicine Sales Quantity Market Share by Type (2019-2030)
 Figure 28. Global Radiopharmaceuticals in Nuclear Medicine Consumption Value Market Share by Type (2019-2030)
 Figure 29. Global Radiopharmaceuticals in Nuclear Medicine Average Price by Type (2019-2030) & (US$/Dose)
 Figure 30. Global Radiopharmaceuticals in Nuclear Medicine Sales Quantity Market Share by Application (2019-2030)
 Figure 31. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2019-2030)
 Figure 32. Global Radiopharmaceuticals in Nuclear Medicine Average Price by Application (2019-2030) & (US$/Dose)
 Figure 33. North America Radiopharmaceuticals in Nuclear Medicine Sales Quantity Market Share by Type (2019-2030)
 Figure 34. North America Radiopharmaceuticals in Nuclear Medicine Sales Quantity Market Share by Application (2019-2030)
 Figure 35. North America Radiopharmaceuticals in Nuclear Medicine Sales Quantity Market Share by Country (2019-2030)
 Figure 36. North America Radiopharmaceuticals in Nuclear Medicine Consumption Value Market Share by Country (2019-2030)
 Figure 37. United States Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030) & (USD Million)
 Figure 38. Canada Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030) & (USD Million)
 Figure 39. Mexico Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030) & (USD Million)
 Figure 40. Europe Radiopharmaceuticals in Nuclear Medicine Sales Quantity Market Share by Type (2019-2030)
 Figure 41. Europe Radiopharmaceuticals in Nuclear Medicine Sales Quantity Market Share by Application (2019-2030)
 Figure 42. Europe Radiopharmaceuticals in Nuclear Medicine Sales Quantity Market Share by Country (2019-2030)
 Figure 43. Europe Radiopharmaceuticals in Nuclear Medicine Consumption Value Market Share by Country (2019-2030)
 Figure 44. Germany Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030) & (USD Million)
 Figure 45. France Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030) & (USD Million)
 Figure 46. United Kingdom Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030) & (USD Million)
 Figure 47. Russia Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030) & (USD Million)
 Figure 48. Italy Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030) & (USD Million)
 Figure 49. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Quantity Market Share by Type (2019-2030)
 Figure 50. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Quantity Market Share by Application (2019-2030)
 Figure 51. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Quantity Market Share by Region (2019-2030)
 Figure 52. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Consumption Value Market Share by Region (2019-2030)
 Figure 53. China Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030) & (USD Million)
 Figure 54. Japan Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030) & (USD Million)
 Figure 55. South Korea Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030) & (USD Million)
 Figure 56. India Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030) & (USD Million)
 Figure 57. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030) & (USD Million)
 Figure 58. Australia Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030) & (USD Million)
 Figure 59. South America Radiopharmaceuticals in Nuclear Medicine Sales Quantity Market Share by Type (2019-2030)
 Figure 60. South America Radiopharmaceuticals in Nuclear Medicine Sales Quantity Market Share by Application (2019-2030)
 Figure 61. South America Radiopharmaceuticals in Nuclear Medicine Sales Quantity Market Share by Country (2019-2030)
 Figure 62. South America Radiopharmaceuticals in Nuclear Medicine Consumption Value Market Share by Country (2019-2030)
 Figure 63. Brazil Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030) & (USD Million)
 Figure 64. Argentina Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030) & (USD Million)
 Figure 65. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales Quantity Market Share by Type (2019-2030)
 Figure 66. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales Quantity Market Share by Application (2019-2030)
 Figure 67. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales Quantity Market Share by Country (2019-2030)
 Figure 68. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Consumption Value Market Share by Country (2019-2030)
 Figure 69. Turkey Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030) & (USD Million)
 Figure 70. Egypt Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030) & (USD Million)
 Figure 71. Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030) & (USD Million)
 Figure 72. South Africa Radiopharmaceuticals in Nuclear Medicine Consumption Value (2019-2030) & (USD Million)
 Figure 73. Radiopharmaceuticals in Nuclear Medicine Market Drivers
 Figure 74. Radiopharmaceuticals in Nuclear Medicine Market Restraints
 Figure 75. Radiopharmaceuticals in Nuclear Medicine Market Trends
 Figure 76. Porters Five Forces Analysis
 Figure 77. Manufacturing Cost Structure Analysis of Radiopharmaceuticals in Nuclear Medicine in 2023
 Figure 78. Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine
 Figure 79. Radiopharmaceuticals in Nuclear Medicine Industrial Chain
 Figure 80. Sales Channel: Direct to End-User vs Distributors
 Figure 81. Direct Channel Pros & Cons
 Figure 82. Indirect Channel Pros & Cons
 Figure 83. Methodology
 Figure 84. Research Process and Data Source

Companies Mentioned

Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Dongcheng